Novo Nordisk A/S Common Stock (NVO)

Other Income/Expenses (Net)

-kr 186.00M

Quarterly · Period ending: · DKK

NVO logo

NVO Other Income/Expenses (Net)

Latest reported-kr 186.00M DKK
NVO Quarterly Other Income/Expenses (Net) · DKK (-kr 985.86M → -kr 186.00M)
High-resolution chart · PNG

NVO other income/expenses (net) history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Other Income/Expenses (Net) — Quarterly (DKK)
Period endingOther Income/Expenses (Net) (DKK)
-186,000,000
2,554,000,000
2,449,000,000
1,835,000,000
356,000,000
-1,758,000,000
-1,180,000,000
562,000,000
-602,000,000
72,000,000
854,000,000
1,150,000,000
366,000,000
-270,000,000
-771,000,000
-2,152,000,000
-1,596,000,000
-1,228,000,000
-521,000,000
-137,000,000
138,000,000
956,000,000
824,000,000
-117,000,000
-422,000,000
-1,281,000,000
-794,000,000
-812,000,000
-1,307,000,000
-1,017,000,000
-413,000,000
-675,000,000
294,000,000
1,161,000,000
524,000,000
418,000,000
-743,000,000
-486,000,000
-264,000,000
-119,000,000
105,000,000
-356,000,000
-811,000,000
-1,844,000,000
-1,934,000,000
-1,372,000,000
-805,000,000
-115,000,000
256,000,000
268,000,000
436,000,000
307,000,000
96,000,000
207,000,000
-120,000,000
-505,000,000
-710,000,000
-328,000,000
-270,000,000
-154,000,000
103,000,000
-128,000,000
361,000,000
-468,000,000
-433,000,000
-65,000,000
-227,000,000
-207,000,000
-206,000,000
-305,000,000
-303,899,000
182,000,000
402,841,000
39,000,000
223,065,400
177,585,000
1,584,245,000
44,648,000
304,013,000
29,410,000
-140,102,000
-153,904,000
-239,601,000
105,453,000
0
275,871,000
285,939,000
83,781,000
24,374,000
90,630,000
-1,823,604,000
-1,637,026,000
-1,607,878,000
326,268,000
12,498,497,000
-6,445,668,000
-5,278,480,000
-6,020,344,000
11,616,682,000
-6,652,111,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.